FDA Approved: TALVEY — Supplemental Application (Janssen Biotech, Inc.)

View source ↗

Summary

FDA approved Janssen Biotech's supplemental application for TALVEY (talquetamab), updating its labeling to reflect the approved changes. TALVEY is a bispecific …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TALVEY (talquetamab)

Snippet

SUPPL AP for TALVEY (TALQUETAMAB)